Thorne Healthtech Stock Current Ratio
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
Thorne HealthTech fundamentals help investors to digest information that contributes to Thorne HealthTech's financial success or failures. It also enables traders to predict the movement of Thorne Stock. The fundamental analysis module provides a way to measure Thorne HealthTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Thorne HealthTech stock.
Thorne |
Thorne HealthTech Company Current Ratio Analysis
Thorne HealthTech's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Thorne HealthTech Current Ratio | 2.91 X |
Most of Thorne HealthTech's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Thorne HealthTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Thorne HealthTech has a Current Ratio of 2.91 times. This is 46.23% higher than that of the Food Products sector and 3.32% lower than that of the Consumer Staples industry. The current ratio for all United States stocks is 34.72% lower than that of the firm.
Thorne Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Thorne HealthTech's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Thorne HealthTech could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics of similar companies.Thorne HealthTech is currently under evaluation in current ratio category among its peers.
Thorne Fundamentals
| Price To Earning | 100.20 X | |||
| Revenue | 228.73 M | |||
| EBITDA | 10.31 M | |||
| Net Income | 14.93 M | |||
| Cash And Equivalents | 27.81 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 47.03 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 2.91 X | |||
| Book Value Per Share | 2.46 X | |||
| Cash Flow From Operations | 5.22 M | |||
| Earnings Per Share | 0.15 X | |||
| Price To Earnings To Growth | 0.09 X | |||
| Target Price | 6.9 | |||
| Number Of Employees | 544 | |||
| Market Capitalization | 259.95 M | |||
| Total Asset | 229.8 M | |||
| Retained Earnings | (116.48 M) | |||
| Working Capital | 77.06 M | |||
| Z Score | 4.15 | |||
| Net Asset | 229.8 M |
About Thorne HealthTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Thorne HealthTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thorne HealthTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thorne HealthTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Thorne HealthTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.Moving together with Thorne Stock
The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |